Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression
- 27 November 2003
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 22 (54) , 8731-8737
- https://doi.org/10.1038/sj.onc.1207079
Abstract
HIPK2 shows overlapping localization with p53 in promyelocytic leukemia (PML) nuclear bodies (PML-NBs) and functionally interacts with p53 to increase gene expression. Here we demonstrate that HIPK2 and the PML-NB resident protein Sp100 synergize for the activation of p53-dependent gene expression. Sp100 and HIPK2 interact and partially colocalize in PML-NBs. The cooperation of HIPK2 and Sp100 for the induction of p21Waf1 is completely dependent on the presence of p53 and the kinase function of HIPK2. Downregulation of Sp100 levels by expression of siRNA does not interfere with p53-mediated transcription, but obviates the enhancing effect of HIPK2. In summary, these experiments reveal a novel function for Sp100 as a coactivator for HIPK2-mediated p53 activation.Keywords
This publication has 30 references indexed in Scilit:
- Homeodomain-Interacting Protein Kinase 1 Modulates Daxx Localization, Phosphorylation, and Transcriptional ActivityMolecular and Cellular Biology, 2003
- Identification and Characterization of HIPK2 Interacting with p73 and Modulating Functions of the p53 Familyin VivoPublished by Elsevier ,2002
- Pondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear BodiesMolecular and Cellular Biology, 2002
- The promyelocytic leukemia nuclear body: sites of activity?Biochemistry and Cell Biology, 2002
- Split personalityNature Reviews Cancer, 2002
- Sp100 Interacts with ETS-1 and Stimulates Its Transcriptional ActivityMolecular and Cellular Biology, 2002
- 3 out of 4 ain't badNature Reviews Cancer, 2002
- SUMO: of branched proteins and nuclear bodiesOncogene, 2001
- Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cellsCell, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993